- Home
- AVA vs NRIX Comparison
AVA vs NRIX Comparison
Compare AVA & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVA | NRIX |
|---|---|---|
| Founded | 1889 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AVA | NRIX |
|---|---|---|
| Price | $36.22 | $22.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $41.00 | $34.36 |
| AVG Volume (30 Days) | 672.4K | ★ 1.4M |
| Earning Date | 11-04-2026 | 10-12-2026 |
| Dividend Yield | ★ 5.50% | N/A |
| EPS Growth | ★ 3.93 | N/A |
| EPS | 1.54 | ★ 3.26 |
| Revenue | ★ $1,964,000,000.00 | $76,987,000.00 |
| Revenue This Year | $2.08 | $834.98 |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | $23.26 | ★ N/A |
| Revenue Growth | 1.34 | ★ 99.31 |
| 52 Week Low | $34.46 | $9.18 |
| 52 Week High | $43.50 | $28.23 |
Technical Indicators
Market Signals| Indicator | AVA | NRIX |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 36.73 |
| Support Level | $34.46 | $22.48 |
| Resistance Level | $43.06 | $24.65 |
| Average True Range (ATR) | 0.57 | 0.94 |
| MACD | 0.20 | -0.09 |
| Stochastic Oscillator | 97.13 | 47.01 |
Price Performance
Historical ComparisonAbout AVA Avista Corporation
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
About NRIX Nurix Therapeutics Inc.
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.